One drug blocks mTOR signaling, and the other stops the blocker from acting anywhere in the body but the brain, lowering the potential for side effects.
The post Two-drug combo blunts autism-linked pathway in brain appeared first on Spectrum | Autism Research News.
Source: Spectrum News